The successful production of animals and embryonic stem cells using somatic cell nuclear transfer (SCNT) has demonstrated the unmatched nuclear reprogramming capacity of the oocyte and helped prove the degree of plasticity of differentiated cells. The introduction of transcription factors to generate induced pluripotent stem cells (iPSCs) displaced SCNT and, due to its ease of implementation, became the method of choice for cell reprogramming. Nonetheless, iPSC derivation remains inefficient and stochastic. This review article focuses on using the oocyte as a source of reprogramming factors, comparing the SCNT and iPSC mechanisms for remodeling chromatin and acquiring pluripotency.
Get full access to this article
View all access options for this article.
References
1.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
2.
MallonBS, HamiltonRS, KozhichOA, JohnsonKR, FannYC, RaoMS and RobeyPG. (2014). Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res, 12:376–386.
3.
ZhouH, WuS, JooJY, ZhuS, HanDW, LinT, TraugerS, BienG, YaoS, et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4:381–384.
4.
ZhouW and FreedCR. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27:2667–2674.
5.
SubramanyamD, LamouilleS, JudsonRL, LiuJY, BucayN, DerynckR and BlellochR. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol, 29:443–448.
6.
Anokye-DansoF, TrivediCM, JuhrD, GuptaM, CuiZ, TianY, ZhangY, YangW, GruberPJ, EpsteinJA and MorriseyEE. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8:376–388.
7.
WarrenL, ManosPD, AhfeldtT, LohYH, LiH, LauF, EbinaW, MandalPK, SmithZD, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7:618–630.
8.
LewandowskiJ and KurpiszM. (2016). Techniques of human embryonic stem cell and induced pluripotent stem cell derivation. Arch Immunol Ther Exp (Warsz), 64:349–370.
9.
CampbellKH, McWhirJ, RitchieWA and WilmutI. (1996). Sheep cloned by nuclear transfer from a cultured cell line. Nature, 380:64–66.
WilmutI, SchniekeAE, McWhirJ, KindAJ and CampbellKH. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature, 385:810–813.
12.
WilmutI, BeaujeanN, de SousaPA, DinnyesA, KingTJ, PatersonLA, WellsDN and YoungLE. (2002). Somatic cell nuclear transfer. Nature, 419:583–586.
13.
TachibanaM, AmatoP, SparmanM, GutierrezNM, Tippner-HedgesR, MaH, KangE, FulatiA, LeeHS, et al. (2013). Human embryonic stem cells derived by somatic cell nuclear transfer. Cell, 153:1228–1238.
14.
WakayamaS, JaktML, SuzukiM, ArakiR, HikichiT, KishigamiS, OhtaH, Van ThuanN, MizutaniE, et al. (2006). Equivalency of nuclear transfer-derived embryonic stem cells to those derived from fertilized mouse blastocysts. Stem Cells, 24:2023–2033.
15.
YamadaM, JohannessonB, SagiI, BurnettLC, KortDH, ProsserRW, PaullD, NestorMW, FreebyM, et al. (2014). Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature, 510:533–536.
16.
BrambrinkT, HochedlingerK, BellG and JaenischR. (2006). ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc Natl Acad Sci U S A, 103:933–938.
17.
BuganimY, FaddahDA and JaenischR. (2013). Mechanisms and models of somatic cell reprogramming. Nat Rev Genet, 14:427–439.
18.
Halley-StottRP and GurdonJB. (2013). Epigenetic memory in the context of nuclear reprogramming and cancer. Brief Funct Genomics, 12:164–173.
19.
Halley-StottRP, PasqueV, AstrandC, MiyamotoK, SimeoniI, JullienJ and GurdonJB. (2010). Mammalian nuclear transplantation to germinal vesicle stage Xenopus oocytes—a method for quantitative transcriptional reprogramming. Methods, 51:56–65.
20.
Halley-StottRP, PasqueV and GurdonJB. (2013). Nuclear reprogramming. Development, 140:2468–2471.
21.
StojkovicM, StojkovicP, LearyC, HallVJ, ArmstrongL, HerbertM, NesbittM, LakoM and MurdochA. (2005). Derivation of a human blastocyst after heterologous nuclear transfer to donated oocytes. Reprod Biomed Online, 11:226–231.
22.
ChungYG, EumJH, LeeJE, ShimSH, SepilianV, HongSW, LeeY, TreffNR, ChoiYH, et al. (2014). Human somatic cell nuclear transfer using adult cells. Cell Stem Cell, 14:777–780.
23.
MaH, MoreyR, O'NeilRC, HeY, DaughtryB, SchultzMD, HariharanM, NeryJR, CastanonR, et al. (2014). Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature, 511:177–183.
24.
LiZ, LuH, YangW, YongJ, ZhangZN, ZhangK, DengH and XuY. (2014). Mouse SCNT ESCs have lower somatic mutation load than syngeneic iPSCs. Stem Cell Rep, 2:399–405.
25.
JohannessonB, SagiI, GoreA, PaullD, YamadaM, Golan-LevT, LiZ, LeDucC, ShenY, et al. (2014). Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell, 15:634–642.
26.
MishraS, KacinE, StamatiadisP, FranckS, Van der JeughtM, MertesH, PenningsG, De SutterP, SermonK, HeindryckxB and GeensM. (2018). The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells. Mol Hum Reprod, 24:173–184.
27.
NishinoK, ToyodaM, Yamazaki-InoueM, FukawataseY, ChikazawaE, SakaguchiH, AkutsuH and UmezawaA. (2011). DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet, 7:e1002085.
28.
BuganimY, FaddahDA, ChengAW, ItskovichE, MarkoulakiS, GanzK, KlemmSL, van OudenaardenA and JaenischR. (2012). Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell, 150:1209–1222.
29.
JullienJ, AstrandC, SzenkerE, GarrettN, AlmouzniG and GurdonJB. (2012). HIRA dependent H3.3 deposition is required for transcriptional reprogramming following nuclear transfer to Xenopus oocytes. Epigenetics Chromatin, 5:17.
30.
NashunB, AkiyamaT, SuzukiMG and AokiF. (2012). Dramatic replacement of histone variants during genome remodeling in nuclear-transferred embryos. Epigenetics, 6:1489–1497.
31.
TeranishiT, TanakaM, KimotoS, OnoY, MiyakoshiK, KonoT and YoshimuraY. (2004). Rapid replacement of somatic linker histones with the oocyte-specific linker histone H1foo in nuclear transfer. Dev Biol, 266:76–86.
32.
SantenardA, Ziegler-BirlingC, KochM, ToraL, BannisterAJ and Torres-PadillaME. (2010). Heterochromatin formation in the mouse embryo requires critical residues of the histone variant H3.3. Nat Cell Biol, 12:853–862.
33.
YangP, WuW and MacfarlanTS. (2014). Maternal histone variants and their chaperones promote paternal genome activation and boost somatic cell reprogramming. BioEssays, 37:52–59.
34.
ShinagawaT, TakagiT, TsukamotoD, TomaruC, HuynhLM, SivaramanP, KumarevelT, InoueK, NakatoR, et al. (2014). Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells. Cell Stem Cell, 14:217–227.
35.
HayakawaK, OhganeJ, TanakaS, YagiS and ShiotaK. (2012). Oocyte-specific linker histone H1foo is an epigenomic modulator that decondenses chromatin and impairs pluripotency. Epigenetics, 7:1029–1036.
36.
KunitomiA, YuasaS, SugiyamaF, SaitoY, SekiT, KusumotoD, KashimuraS, TakeiM, TohyamaS, et al. (2016). H1foo has a pivotal role in qualifying induced pluripotent stem cells. Stem Cell Rep, 6:825–833.
37.
FilipescuD, SzenkerE and AlmouzniG. (2013). Developmental roles of histone H3 variants and their chaperones. Trends Genet, 29:630–640.
38.
LoppinB, BonnefoyE, AnselmeC, LaurenconA, KarrTL and CoubleP. (2005). The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature, 437:1386–1390.
39.
WenD, BanaszynskiLA, LiuY, GengF, NohKM, XiangJ, ElementoO, RosenwaksZ, AllisCD and RafiiS. (2014). Histone variant H3.3 is an essential maternal factor for oocyte reprogramming. Proc Natl Acad Sci U S A, 111:7325–7330.
40.
LinCJ, KohFM, WongP, ContiM and Ramalho-SantosM. (2014). Hira-mediated H3.3 incorporation is required for DNA replication and ribosomal RNA transcription in the mouse zygote. Dev Cell, 30:268–279.
41.
MontellierE, BoussouarF, RousseauxS, ZhangK, BuchouT, FenailleF, ShiotaH, DebernardiA, HeryP, et al. (2013). Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B. Genes Dev, 27:1680–1692.
42.
ShinagawaT, HuynhLM, TakagiT, TsukamotoD, TomaruC, KwakHG, DohmaeN, NoguchiJ and IshiiS. (2015). Disruption of Th2a and Th2b genes causes defects in spermatogenesis. Development, 142:1287–1292.
43.
HuynhLM, ShinagawaT and IshiiS. (2016). Two histone variants TH2A and TH2B enhance human induced pluripotent stem cell generation. Stem Cells Dev, 25:251–258.
44.
KaferGR, LehnertSA, PantaleonM, KayePL and MoserRJ. (2010). Expression of genes coding for histone variants and histone-associated proteins in pluripotent stem cells and mouse preimplantation embryos. Gene Expr Patterns, 10:299–305.
45.
NashunB, YukawaM, LiuH, AkiyamaT and AokiF. (2010). Changes in the nuclear deposition of histone H2A variants during pre-implantation development in mice. Development, 137:3785–3794.
46.
PereiraAF, MeloLM, FreitasVJ and SalamoneDF. (2015). Phosphorylated H2AX in parthenogenetically activated, in vitro fertilized and cloned bovine embryos. Zygote, 23:485–493.
47.
Ziegler-BirlingC, HelmrichA, ToraL and Torres-PadillaME. (2009). Distribution of p53 binding protein 1 (53BP1) and phosphorylated H2A.X during mouse preimplantation development in the absence of DNA damage. Int J Dev Biol, 53:1003–1011.
48.
BohrerRC, CheL, GoncalvesPB, DuggavathiR and BordignonV. (2013). Phosphorylated histone H2A.x in porcine embryos produced by IVF and somatic cell nuclear transfer. Reproduction, 146:325–333.
49.
BanathJP, BanuelosCA, KlokovD, MacPhailSM, LansdorpPM and OlivePL. (2009). Explanation for excessive DNA single-strand breaks and endogenous repair foci in pluripotent mouse embryonic stem cells. Exp Cell Res, 315:1505–1520.
50.
TurinettoV, OrlandoL, Sanchez-RipollY, KumpfmuellerB, StormMP, PorceddaP, MinieriV, SaviozziS, AccomassoL, et al. (2012). High basal gammaH2AX levels sustain self-renewal of mouse embryonic and induced pluripotent stem cells. Stem Cells, 30:1414–1423.
51.
WuT, LiuY, WenD, TsengZ, TahmasianM, ZhongM, RafiiS, StadtfeldM, HochedlingerK and XiaoA. (2014). Histone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs. Cell Stem Cell, 15:281–294.
52.
KocabasAM, CrosbyJ, RossPJ, OtuHH, BeyhanZ, CanH, TamWL, RosaGJ, HalgrenRG, et al. (2006). The transcriptome of human oocytes. Proc Natl Acad Sci U S A, 103:14027–14032.
53.
Gonzalez-MunozE, Arboleda-EstudilloY, OtuHH and CibelliJB. (2014). Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. Science, 345:822–825.
54.
DasC, LuciaMS, HansenKC and TylerJK. (2009). CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature, 459:113–117.
55.
HoulardM, BerlivetS, ProbstAV, QuivyJP, HeryP, AlmouzniG and GerardM. (2006). CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells. PLoS Genet, 2:e181.
56.
HatanakaY, InoueK, OikawaM, KamimuraS, OgonukiN, KodamaY, OhkawaY, TsukadaY and OguraA. (2015). Histone chaperone CAF-1 mediates repressive histone modifications to protect preimplantation mouse embryos from endogenous retrotransposons. Proc Natl Acad Sci U S A, 112:14641–14646.
BlackwellL, NorrisJ, SutoCM and JanzenWP. (2008). The use of diversity profiling to characterize chemical modulators of the histone deacetylases. Life Sci, 82:1050–1058.
59.
de RuijterAJ, van GennipAH, CaronHN, KempS and van KuilenburgAB. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J, 370:737–749.
60.
PanH, O'BrienJ, M, WigglesworthK, EppigJJ and SchultzRM. (2005). Transcript profiling during mouse oocyte development and the effect of gonadotropin priming and development in vitro. Dev Biol, 286:493–506.
61.
YoshidaN, BrahmajosyulaM, ShojiS, AmanaiM and PerryAC. (2007). Epigenetic discrimination by mouse metaphase II oocytes mediates asymmetric chromatin remodeling independently of meiotic exit. Dev Biol, 301:464–477.
62.
McGrawS, RobertC, MassicotteL and SirardMA. (2003). Quantification of histone acetyltransferase and histone deacetylase transcripts during early bovine embryo development. Biol Reprod, 68:383–389.
63.
WangF, KouZ, ZhangY and GaoS. (2007). Dynamic reprogramming of histone acetylation and methylation in the first cell cycle of cloned mouse embryos. Biol Reprod, 77:1007–1016.
64.
KishigamiS, MizutaniE, OhtaH, HikichiT, ThuanNV, WakayamaS, BuiHT and WakayamaT. (2006). Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem Biophys Res Commun, 340:183–189.
65.
FariftehF, SalehiM, BandehpourM, NarimanM, Ghafari NovinM, HosseiniT, NematollahiS, NoroozianM, KeshavarziS and HosseiniA. (2014). Histone modification of embryonic stem cells produced by somatic cell nuclear transfer and fertilized blastocysts. Cell J, 15:316–323.
66.
OguraA, InoueK and WakayamaT. (2013). Recent advancements in cloning by somatic cell nuclear transfer. Philos Trans R Soc Lond B Biol Sci, 368:20110329:20110329.
67.
XuW, WangY, LiY, WangL, XiongX, SuJ and ZhangY. (2012). Valproic acid improves the in vitro development competence of bovine somatic cell nuclear transfer embryos. Cell Reprogram, 14:138–145.
68.
LiuL, LiuY, GaoF, SongG, WenJ, GuanJ, YinY, MaX, TangB and LiZ. (2012). Embryonic development and gene expression of porcine SCNT embryos treated with sodium butyrate. J Exp Zool B Mol Dev Evol, 318:224–234.
69.
OnoT, LiC, MizutaniE, TerashitaY, YamagataK and WakayamaT. (2010). Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice. Biol Reprod, 83:929–937.
70.
KretsovaliA, HadjimichaelC and CharmpilasN. (2012). Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. Stem Cells Int, 2012:184154.
71.
SongBS, YoonSB, SimBW, KimYH, ChaJJ, ChoiSA, JeongKJ, KimJS, HuhJW, et al. (2014). Valproic acid enhances early development of bovine somatic cell nuclear transfer embryos by alleviating endoplasmic reticulum stress. Reprod Fertil Dev, 26:432–440.
72.
MiyoshiK, MoriH, MizobeY, AkasakaE, OzawaA, YoshidaM and SatoM. (2010). Valproic acid enhances in vitro development and Oct-3/4 expression of miniature pig somatic cell nuclear transfer embryos. Cell Reprogram, 12:67–74.
73.
MaliP, ChouBK, YenJ, YeZ, ZouJ, DoweyS, BrodskyRA, JE OhmW, YuSB, et al. (2010). Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells, 28:713–720.
74.
HuangfuD, OsafuneK, MaehrR, GuoW, EijkelenboomA, ChenS, MuhlesteinW and MeltonDA. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol, 26:1269–1275.
HuangfuD, MaehrR, GuoW, EijkelenboomA, SnitowM, ChenAE and MeltonDA. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol, 26:795–797.
77.
FengB, NgJH, HengJC and NgHH. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 4:301–312.
78.
XieW, SongC, YoungNL, SperlingAS, XuF, SridharanR, ConwayAE, GarciaBA, PlathK, ClarkAT and GrunsteinM. (2009). Histone H3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell, 33:417–427.
79.
TanY, XueY, SongC and GrunsteinM. (2013). Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc Natl Acad Sci U S A, 110:11493–11498.
80.
Ziegler-BirlingC, DaujatS, SchneiderR and Torres-PadillaME. (2016). Dynamics of histone H3 acetylation in the nucleosome core during mouse pre-implantation development. Epigenetics, 11:553–562.
81.
SuJ, WangY, LiR, PengH, HuaS, LiQ, QuanF, GuoZ and ZhangY. (2012). Oocytes selected using BCB staining enhance nuclear reprogramming and the in vivo development of SCNT embryos in cattle. PLoS One, 7:e36181.
82.
KageyamaS, LiuH, KanekoN, OogaM, NagataM and AokiF. (2007). Alterations in epigenetic modifications during oocyte growth in mice. Reproduction, 133:85–94.
83.
WuFR, LiuY, ShangMB, YangXX, DingB, GaoJG, WangR and LiWY. (2012). Differences in H3K4 trimethylation in in vivo and in vitro fertilization mouse preimplantation embryos. Genet Mol Res, 11:1099–1108.
84.
LachnerM, O'SullivanRJ and JenuweinT. (2003). An epigenetic road map for histone lysine methylation. J Cell Sci, 116:2117–2124.
WysockaJ, SwigutT, MilneTA, DouY, ZhangX, BurlingameAL, RoederRG, BrivanlouAH and AllisCD. (2005). WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell, 121:859–872.
87.
LinH, MinZ and TaoQ. (2016). The MLL/Setd1b methyltransferase is required for the Spemann's organizer gene activation in Xenopus. Mech Dev, 142:1–9.
88.
AngYS, TsaiSY, LeeDF, MonkJ, SuJ, RatnakumarK, DingJ, GeY, DarrH, et al. (2011). C Schaniel and IR Lemischka. Cell, 145:183–197.
89.
HormansederE, SimeoneA, AllenGE, BradshawCR, FiglmullerM, GurdonJ and JullienJ. (2017). H3K4 methylation-dependent memory of somatic cell identity inhibits reprogramming and development of nuclear transfer embryos. Cell Stem Cell, 21:135–143 e6.
90.
LiuW, LiuX, WangC, GaoY, GaoR, KouX, ZhaoY, LiJ, WuY, et al. (2016). Identification of key factors conquering developmental arrest of somatic cell cloned embryos by combining embryo biopsy and single-cell sequencing. Cell Discov, 2:16010.
DeyBK, StalkerL, SchnerchA, BhatiaM, Taylor-PapidimitriouJ and WynderC. (2008). The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by blocking terminal differentiation. Mol Cell Biol, 28:5312–5327.
94.
SchmitzSU, AlbertM, MalatestaM, MoreyL, JohansenJV, BakM, TommerupN, AbarrateguiI and HelinK. (2011). Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J, 30:4586–4600.
95.
KidderBL, HuG, YuZX, LiuC and ZhaoK. (2013). Extended self-renewal and accelerated reprogramming in the absence of Kdm5b. Mol Cell Biol, 33:4793–4810.
96.
Epsztejn-LitmanS, FeldmanN, Abu-RemailehM, ShufaroY, GersonA, UedaJ, DeplusR, FuksF, ShinkaiY, CedarH and BergmanY. (2008). De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol, 15:1176–1183.
97.
AntonyJ, ObackF, ChamleyLW, ObackB and LaibleG. (2013). Transient JMJD2B-mediated reduction of H3K9me3 levels improves reprogramming of embryonic stem cells into cloned embryos. Mol Cell Biol, 33:974–983.
98.
MatobaS, LiuY, LuF, IwabuchiKA, ShenL, InoueA and ZhangY. (2014). Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell, 159:884–895.
99.
SoufiA, DonahueG and ZaretKS. (2012). Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell, 151:994–1004.
100.
ChenJ, LiuH, LiuJ, QiJ, WeiB, YangJ, LiangH, ChenY, WuY, et al. (2013). H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet, 45:34–42.
101.
SridharanR, Gonzales-CopeM, ChronisC, BonoraG, McKeeR, HuangC, PatelS, LopezD, MishraN, et al. (2013). Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1gamma in reprogramming to pluripotency. Nat Cell Biol, 15:872–882.
102.
OnderTT, KaraN, CherryA, SinhaAU, ZhuN, BerntKM, CahanP, MarcarciBO, UnternaehrerJ, et al. (2012). Chromatin-modifying enzymes as modulators of reprogramming. Nature, 483:598–602.
103.
YeapLS, HayashiK and SuraniMA. (2009). ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin, 2:12.
104.
YuanP, HanJ, GuoG, OrlovYL, HussM, LohYH, YawLP, RobsonP, LimB and NgHH. (2009). Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev, 23:2507–2520.
105.
ShiY, DespontsC, DoJT, HahmHS, ScholerHR and DingS. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3:568–574.
LinT and WuS. (2015). Reprogramming with small molecules instead of exogenous transcription factors. Stem Cells Int, 2015:794632.
108.
ChungYG, MatobaS, LiuY, EumJH, LuF, JiangW, LeeJE, SepilianV, ChaKY, LeeDR and ZhangY. (2015). Histone demethylase expression enhances human somatic cell nuclear transfer efficiency and promotes derivation of pluripotent stem cells. Cell Stem Cell, 17:758–766.
109.
LiuX, WangY, GaoY, SuJ, ZhangJ, XingX, ZhouC, Yao,K, AnQ and ZhangY. (2018). H3K9 demethylase KDM4E is an epigenetic regulator for bovine embryonic development and a defective factor for nuclear reprogramming. Development, 145:pii: dev158261.
110.
HuangJ, ZhangH, YaoJ, QinG, WangF, WangX, LuoA, ZhengQ, CaoC and ZhaoJ. (2016). BIX-01294 increases pig cloning efficiency by improving epigenetic reprogramming of somatic cell nuclei. Reproduction, 151:39–49.
111.
ZhangZ, ZhaiY, MaX, ZhangS, AnX, YuH and LiZ. (2018). Down-regulation of H3K4me3 by MM-102 facilitates epigenetic reprogramming of porcine somatic cell nuclear transfer embryos. Cell Physiol Biochem, 45:1529–1540.
ZhangA, XuB, SunY, LuX, GuR, WuL, FengY and XuC. (2012). Dynamic changes of histone H3 trimethylated at positions K4 and K27 in human oocytes and preimplantation embryos. Fertil Steril, 98:1009–1016.
114.
RossPJ, RaginaNP, RodriguezRM, IagerAE, SiripattarapravatK, Lopez-CorralesN and CibelliJB. (2008). Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development. Reproduction, 136:777–785.
115.
XieB, ZhangH, WeiR, LiQ, WengX, KongQ and LiuZ. (2016). Histone H3 lysine 27 trimethylation acts as an epigenetic barrier in porcine nuclear reprogramming. Reproduction, 151:9–16.
116.
DingX, WangX, SontagS, QinJ, WanekP, LinQ and ZenkeM. (2014). The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Stem Cells Dev, 23:931–940.
117.
HusseinSM, PuriMC, TongePD, BeneventoM, CorsoAJ, ClancyJL, MosbergenR, LiM, LeeDS, et al. (2014). Genome-wide characterization of the routes to pluripotency. Nature, 516:198–206.
118.
TongePD, CorsoAJ, MonettiC, HusseinSM, PuriMC, MichaelIP, LiM, LeeDS, MarJC, et al. (2014). Divergent reprogramming routes lead to alternative stem-cell states. Nature, 516:192–197.
119.
KloseRJ, KallinEM and ZhangY. (2006). JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet, 7:715–727.
120.
MansourAA, GafniO, WeinbergerL, ZviranA, AyyashM, RaisY, KrupalnikV, ZerbibM, Amann-ZalcensteinD, et al. (2012). The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature, 488:409–413.
121.
LiangG, HeJ and ZhangY. (2012). Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol, 14:457–466.
122.
MoonJH, HeoJS, KimJS, JunEK, LeeJH, KimA, KimJ, WhangKY, KangYK, et al. (2011). Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res, 21:1305–1315.
123.
PuschendorfM, TerranovaR, BoutsmaE, MaoX, IsonoK, BrykczynskaU, KolbC, OtteAP, KosekiH, et al. (2008). PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos. Nat Genet, 40:411–420.
124.
KangE, WuG, MaH, LiY, Tippner-HedgesR, TachibanaM, SparmanM, WolfDP, ScholerHR and MitalipovS. (2014). Nuclear reprogramming by interphase cytoplasm of two-cell mouse embryos. Nature, 509:101–104.
125.
LessardJ and SauvageauG. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423:255–260.
126.
ParkIK, QianD, KielM, BeckerMW, PihaljaM, WeissmanIL, MorrisonSJ and ClarkeMF. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 423:302–305.
127.
ParkIK, MorrisonSJ and ClarkeMF. (2004). Bmi1, stem cells, and senescence regulation. J Clin Invest, 113:175–179.
128.
HillPW, AmourouxR and HajkovaP. (2014). DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. Genomics, 104:324–333.
129.
OswaldJ, EngemannS, LaneN, MayerW, OlekA, FundeleR, DeanW, ReikW and WalterJ. (2000). Active demethylation of the paternal genome in the mouse zygote. Curr Biol, 10:475–478.
130.
LeitchHG, McEwenKR, TurpA, EnchevaV, CarrollT, GraboleN, MansfieldW, NashunB, KnezovichJG, et al. (2013). Naive pluripotency is associated with global DNA hypomethylation. Nat Struct Mol Biol, 20:311–316.
131.
MikkelsenTS, HannaJ, ZhangX, KuM, WernigM, SchorderetP, BernsteinBE, JaenischR, LanderES and MeissnerA. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature, 454:49–55.
132.
IyerLM, TahilianiM, RaoA and AravindL. (2009). Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle, 8:1698–1710.
133.
GuTP, GuoF, YangH, WuHP, XuGF, LiuW, XieZG, ShiL, HeX, et al. (2011). The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature, 477:606–610.
134.
CostaY, DingJ, TheunissenTW, FaiolaF, HoreTA, ShliahaPV, FidalgoM, SaundersA, LawrenceM, et al. (2013). NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature, 495:370–374.
135.
DoegeCA, InoueK, YamashitaT, RheeDB, TravisS, FujitaR, GuarnieriP, BhagatG, VantiWB, et al. (2012). Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature, 488:652–655.
136.
GaoY, ChenJ, LiK, WuT, HuangB, LiuW, KouX, ZhangY, HuangH, et al. (2013). Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell, 12:453–469.
137.
ChenJ, GaoY, HuangH, XuK, ChenX, JiangY, LiH, GaoS, TaoY, et al. (2015). The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells. Stem Cells, 33:686–698.
138.
Bermejo-AlvarezP, Ramos-IbeasP, ParkKE, PowellAP, VansandtL, DerekB, RamirezMA, Gutierrez-AdanA and TeluguBP. (2015). Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells. Sci Rep, 5:13691.
139.
SinghalN, GraumannJ, WuG, Arauzo-BravoMJ, HanDW, GreberB, GentileL, MannM and ScholerHR. (2010). Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell, 141:943–955.
140.
GurdonJB. (1968). Changes in somatic cell nuclei inserted into growing and maturing amphibian oocytes. J Embryol Exp Morphol, 20:401–414.
141.
BlauHM, ChiuCP and WebsterC. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell, 32:1171–1180.
142.
JullienJ, MiyamotoK, PasqueV, AllenGE, BradshawCR, GarrettNJ, Halley-StottRP, KimuraH, OhsumiK and GurdonJB. (2014). Hierarchical molecular events driven by oocyte-specific factors lead to rapid and extensive reprogramming. Mol Cell, 55:524–536.
143.
BhutaniN, BradyJJ, DamianM, SaccoA, SY, BlauHM. (2010). Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature, 463:1042–1047.
144.
TsubouchiT, Soza-RiedJ, BrownK, PiccoloFM, CantoneI, LandeiraD, BagciH, HocheggerH, MerkenschlagerM and FisherAG. (2013). DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell, 152:873–883.
145.
WangT, ChenK, ZengX, YangJ, WuY, ShiX, QinB, ZengL, EstebanMA, PanG and PeiD. (2011). The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell, 9:575–587.
146.
HannaJ, SahaK, PandoB, van ZonJ, LengnerCJ, CreyghtonMP, van OudenaardenA and JaenischR. (2009). Direct cell reprogramming is a stochastic process amenable to acceleration. Nature, 462:595–601.
147.
FoshayKM, LooneyTJ, ChariS, MaoFF, LeeJH, ZhangL, FernandesCJ, BakerSW, CliftKL, et al. (2012). Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol Cell, 46:159–170.
148.
WangB, PfeifferMJ, SchwarzerC, Arauzo-BravoMJ and BoianiM. (2014). DNA replication is an integral part of the mouse oocyte's reprogramming machinery. PLoS One, 9:e97199.
149.
MacAlpineDM and AlmouzniG. (2013). Chromatin and DNA replication. Cold Spring Harb Perspect Biol, 5:a010207.
150.
AlabertC and GrothA. (2012). Chromatin replication and epigenome maintenance. Nat Rev Mol Cell Biol, 13:153–167.
151.
WolffeAP. (1991). Implications of DNA replication for eukaryotic gene expression. J Cell Sci, 99:201–206.
152.
SaekiH, OhsumiK, AiharaH, ItoT, HiroseS, UraK and KanedaY. (2005). Linker histone variants control chromatin dynamics during early embryogenesis. Proc Natl Acad Sci U S A, 102:5697–5702.
153.
TamadaH, Van ThuanN, ReedP, NelsonD, Katoku-KikyoN, WudelJ, WakayamaT and KikyoN. (2006). Chromatin decondensation and nuclear reprogramming by nucleoplasmin. Mol Cell Biol, 26:1259–1271.
154.
MiyamotoK, PasqueV and GurdonJB. (2011). Nuclear actin in transcriptional reprogramming by oocytes: are actin nucleators key players?. Cell Cycle, 10:3040–3041.
155.
MiyamotoK, TeperekM, YusaK, AllenGE, BradshawCR and GurdonJB. (2013). Nuclear Wave1 is required for reprogramming transcription in oocytes and for normal development. Science, 341:1002–1005.
156.
BuiHT, WakayamaS, KishigamiS, ParkKK, KimJH, ThuanNV and WakayamaT. (2010). Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. Biol Reprod, 83:454–463.
157.
AkhtarW and VeenstraGJ. (2009). TBP2 is a substitute for TBP in Xenopus oocyte transcription. BMC Biol, 7:45.
158.
FreimanRN, AlbrightSR, ZhengS, ShaWC, HammerRE and TjianR. (2001). Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. Science, 293:2084–2087.
159.
GazdagE, SantenardA, Ziegler-BirlingC, AltobelliG, PochO, ToraL and Torres-PadillaME. (2009). TBP2 is essential for germ cell development by regulating transcription and chromatin condensation in the oocyte. Genes Dev, 23:2210–2223.
160.
GelesKG, FreimanRN, LiuWL, ZhengS, VoroninaE and TjianR. (2006). Cell-type-selective induction of c-jun by TAF4b directs ovarian-specific transcription networks. Proc Natl Acad Sci U S A, 103:2594–2599.
161.
TakahashiK, SakuraiN, EmuraN, HashizumeT and SawaiK. (2015). Effects of downregulating GLIS1 transcript on preimplantation development and gene expression of bovine embryos. J Reprod Dev, 61:369–374.
162.
MaekawaM, YamaguchiK, NakamuraT, ShibukawaR, KodanakaI, IchisakaT, KawamuraY, MochizukiH, GoshimaN and YamanakaS. (2011). Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature, 474:225–229.
163.
XieD, ChenCC, PtaszekLM, XiaoS, CaoX, FangF, NgHH, LewinHA, CowanC and ZhongS. (2010). Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species. Genome Res, 20:804–815.
164.
ZengF, BaldwinDA and SchultzRM. (2004). Transcript profiling during preimplantation mouse development. Dev Biol, 272:483–496.
165.
ZhangP, ZucchelliM, BruceS, HambilikiF, Stavreus-EversA, LevkovL, SkottmanH, KerkelaE, KereJ and HovattaO. (2009). Transcriptome profiling of human pre-implantation development. PLoS One, 4:e7844.
166.
VassenaR, BoueS, Gonzalez-RocaE, AranB, AuerH, VeigaA and Izpisua BelmonteJC. (2011). Waves of early transcriptional activation and pluripotency program initiation during human preimplantation development. Development, 138:3699–3709.
167.
Geoffrey SchiebingerJS, TabakaM, ClearyB, SubramanianV, SolomonA, LiuSiyan, LinS, BerubeP, LeeL, et al. (2017). Reconstruction of developmental landscapes by optimal-transport analysis of single-cell gene expression sheds light on cellular reprogramming.bioRxiv Beta. https://doi.org/10.1101/191056.
168.
RajkovicA, YanC, YanW, KlysikM and MatzukMM. (2002). Obox, a family of homeobox genes preferentially expressed in germ cells. Genomics, 79:711–717.
169.
KimHM, AhnHJ, LeeHS, LeeKA, LeeSM, KimHH, KimKS and ParkKS. (2010). Obox4 regulates the expression of histone family genes and promotes differentiation of mouse embryonic stem cells. FEBS Lett, 584:605–611.
170.
ChengWC, Hsieh-LiHM, YehYJ and LiH. (2007). Mice lacking the Obox6 homeobox gene undergo normal early embryonic development and are fertile. Dev Dyn, 236:2636–2642.
171.
ChekulaevaM and FilipowiczW. (2009). Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol, 21:452–460.
172.
KimVN, HanJ and SiomiMC. (2009). Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol, 10:126–139.
173.
SiomiMC, SatoK, PezicD and AravinAA. (2011). Piwi-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol, 12:246–258.
174.
OhnishiY, TotokiY, ToyodaA, WatanabeT, YamamotoY, TokunagaK, SakakiY, SasakiH and HohjohH. (2010). Small RNA class transition from siRNA/piRNA to miRNA during pre-implantation mouse development. Nucleic Acids Res, 38:5141–5151.
175.
Garcia-LopezJ, Hourcade JdeD, AlonsoL, CardenasDB and del MazoJ. (2014). Global characterization and target identification of piRNAs and endo-siRNAs in mouse gametes and zygotes. Biochim Biophys Acta, 1839:463–475.
176.
YangCX, DuZQ, WrightEC, RothschildMF, PratherRS and RossJW. (2012). Small RNA profile of the cumulus-oocyte complex and early embryos in the pig. Biol Reprod, 87:117.
177.
MeltonC, JudsonRL and BlellochR. (2010). Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature, 463:621–626.
178.
MondouE, DufortI, GohinM, FournierE and SirardMA. (2012). Analysis of microRNAs and their precursors in bovine early embryonic development. Mol Hum Reprod, 18:425–434.
179.
TangF, KanedaM, O'CarrollD, HajkovaP, BartonSC, SunYA, LeeC, TarakhovskyA, LaoK and SuraniMA. (2007). Maternal microRNAs are essential for mouse zygotic development. Genes Dev, 21:644–648.
180.
HossainMM, GhanemN, HoelkerM, RingsF, PhatsaraC, TholenE, SchellanderK and TesfayeD. (2009). Identification and characterization of miRNAs expressed in the bovine ovary. BMC Genomics, 10:443.
181.
ZiXD, LuJY and MaL. (2017). Identification and comparative analysis of the ovarian microRNAs of prolific and non-prolific goats during the follicular phase using high-throughput sequencing. Sci Rep, 7:1921.
182.
AssouS, T, D Haouzi, PhilippeN, LecellierCH, PiquemalD, CommesT, Aït-AhmedO, DechaudH and HamamahS. (2013). MicroRNAs: new candidates for the regulation of the human cumulus-oocyte complex. Hum Reprod, 28:3038–3049.
183.
FlemrM, MaJ, SchultzRM and SvobodaP. (2010). P-body loss is concomitant with formation of a messenger RNA storage domain in mouse oocytes. Biol Reprod, 82:1008–1017.
184.
MaJ, FlemrM, SteinP, BerningerP, MalikR, ZavolanM, SvobodaP and SchultzRM. (2010). MicroRNA activity is suppressed in mouse oocytes. Curr Biol, 20:265–270.
185.
SvobodaP and FlemrM. (2010). The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency. EMBO Rep, 11:590–597.
186.
FlemrM, MoravecM, LibovaV, SedlacekR and SvobodaP. (2014). Lin28a is dormant, functional, and dispensable during mouse oocyte-to-embryo transition. Biol Reprod, 90:131.
187.
SuhN, BaehnerL, MoltzahnF, MeltonC, ShenoyA, ChenJ and BlellochR. (2010). MicroRNA function is globally suppressed in mouse oocytes and early embryos. Curr Biol, 20:271–277.
188.
FlemrM, MalikR, FrankeV, NejepinskaJ, SedlacekR, VlahovicekK and SvobodaP. (2013). A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes. Cell, 155:807–816.
189.
XuN, PapagiannakopoulosT, PanG, ThomsonJA and KosikKS. (2009). MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell, 137:647–658.
190.
TayY, ZhangJ, ThomsonAM, LimB and RigoutsosI. (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 455:1124–1128.
191.
WangY, BaskervilleS, ShenoyA, BabiarzJE, BaehnerL and BlellochR. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet, 40:1478–1483.
192.
TataPR, TataNR, KuhlM and SirbuIO. (2011). Identification of a novel epigenetic regulatory region within the pluripotency associated microRNA cluster, EEmiRC. Nucleic Acids Res, 39:3574–3581.
LiZ, YangCS, NakashimaK and RanaTM. (2011). Small RNA-mediated regulation of iPS cell generation. EMBO J, 30:823–834.
195.
MiyoshiN, IshiiH, NaganoH, HaraguchiN, DewiDL, KanoY, NishikawaS, TanemuraM, MimoriK, et al. (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell, 8:633–638.
196.
ZhangJ, QuP, ZhouC, LiuX, MaX, WangM, WangY, SuJ, LiuJ and ZhangY. (2017). MicroRNA-125b is a key epigenetic regulatory factor that promotes nuclear transfer reprogramming. J Biol Chem, 292:15916–15926.
197.
JiangC, QinB, LiuG, SunX, ShiH, DingS, LiuY, ZhuM, ChenX and ZhaoC. (2016). MicroRNA-184 promotes differentiation of the retinal pigment epithelium by targeting the AKT2/mTOR signaling pathway. Oncotarget, 7:52340–52353.
198.
Shalom-FeuersteinR, SerrorL, De La Forest DivonneS, PetitI, AberdamE, CamargoL, DamourO, VigourouxC, SolomonA, et al. (2012). Pluripotent stem cell model reveals essential roles for miR-450b-5p and miR-184 in embryonic corneal lineage specification. Stem Cells, 30:898–909.
199.
ParsonsXH. (2012). MicroRNA profiling reveals distinct mechanisms governing cardiac and neural lineage-specification of pluripotent human embryonic stem cells. J Stem Cell Res Ther, 2::124.
200.
WangL, SuW, DuW, XuY, WangL, KongD, HanZ, ZhengG and LiZ. (2015). Gene and microRNA profiling of human induced pluripotent stem cell-derived endothelial cells. Stem Cell Rev, 11:219–227.
201.
HysolliE, TanakaY, SuJ, KimKY, ZhongT, JanknechtR, ZhouXL, GengL, QiuC, et al. (2016). Regulation of the DNA methylation landscape in human somatic cell reprogramming by the miR-29 family. Stem Cell Rep, 7:43–54.
202.
ZhongX, LiN, LiangS, HuangQ, CoukosG and ZhangL. (2010). Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J Biol Chem, 285:41961–41971.
203.
VishnubalajiR, HamamR, YueS, Al-ObeedO, KassemM, LiuFF, AldahmashA and AlajezNM. (2016). MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1. Oncotarget, 7:35789–35802.
204.
NejepinskaJ, MalikR, FilkowskiJ, FlemrM, FilipowiczW and SvobodaP. (2012). dsRNA expression in the mouse elicits RNAi in oocytes and low adenosine deamination in somatic cells. Nucleic Acids Res, 40:399–413.
205.
SvobodaP, FrankeV and SchultzRM. (2015). Sculpting the transcriptome During the oocyte-to-embryo transition in mouse. Curr Top Dev Biol, 113:305–349.
206.
WeickEM and MiskaEA. (2014). piRNAs: from biogenesis to function. Development, 141:3458–3471.
207.
CarmellMA, GirardA, van de KantHJ, Bourc'hisD, BestorTH, de RooijDG and HannonGJ. (2007). MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell, 12:503–514.
208.
DengW and LinH. (2002). Miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. Dev Cell, 2:819–830.
209.
Kuramochi-MiyagawaS, KimuraT, IjiriTW, IsobeT, AsadaN, FujitaY, IkawaM, IwaiN, OkabeM, et al. (2004). Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development, 131:839–849.
210.
RooversEF, RosenkranzD, MahdipourM, HanCT, HeN, Chuva de Sousa LopesSM, van der WesterlakenLA, ZischlerH, ButterF, RoelenBA and KettingRF. (2015). Piwi proteins and piRNAs in mammalian oocytes and early embryos. Cell Rep, 10:2069–2082.
211.
UlitskyI and BartelDP. (2013). lincRNAs: genomics, evolution, and mechanisms. Cell, 154:26–46.
212.
DerrienT, JohnsonR, BussottiG, TanzerA, DjebaliS, TilgnerH, GuernecG, MartinD, MerkelA, et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res, 22:1775–1789.
213.
RinnJL and ChangHY. (2012). Genome regulation by long noncoding RNAs. Annu Rev Biochem, 81:145–166.
214.
UlitskyI, ShkumatavaA, JanCH, SiveH and BartelDP. (2011). Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell, 147:1537–1550.
215.
JohnssonP, LipovichL, GranderD and MorrisKV. (2014). Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta, 1840:1063–1071.
216.
GuttmanM, AmitI, GarberM, FrenchC, LinMF, FeldserD, HuarteM, ZukO, CareyBW, et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458:223–227.
217.
GuttmanM, GarberM, LevinJZ, DonagheyJ, RobinsonJ, AdiconisX, FanL, KoziolMJ, GnirkeA, et al. (2010). Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol, 28:503–510.
218.
NgSY, JohnsonR and StantonLW. (2012). Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J, 31:522–533.
219.
Sheik MohamedJ, GaughwinPM, LimB, RobsonP and LipovichL. (2010). Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA, 16:324–337.
220.
ParanjpeSS, JacobiUG, van HeeringenSJ and VeenstraGJ. (2013). A genome-wide survey of maternal and embryonic transcripts during Xenopus tropicalis development. BMC Genomics, 14:762.
221.
HamazakiN, UesakaM, NakashimaK, AgataK and ImamuraT. (2015). Gene activation-associated long noncoding RNAs function in mouse preimplantation development. Development, 142:910–920.
222.
CaballeroJ, GilbertI, FournierE, GagneD, ScantlandS, MacaulayA and RobertC. (2014). Exploring the function of long non-coding RNA in the development of bovine early embryos. Reprod Fertil Dev, 27:40–52.
223.
YanL, YangM, GuoH, YangL, WuJ, LiR, LiuP, LianY, ZhengX, et al. (2013). Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol, 20:1131–1139.
224.
BouckenheimerJ, AssouS, RiquierS, HouC, PhilippeN, SansacC, Lavabre-BertrandT, CommesT, LemaitreJM, BoureuxA and De VosJ. (2016). Long non-coding RNAs in human early embryonic development and their potential in ART. Hum Reprod Update, 23:19–40.
225.
PfeifferMJ, SiatkowskiM, PaudelY, BalbachST, BaeumerN, CrosettoN, DrexlerHC, FuellenG and BoianiM. (2011). Proteomic analysis of mouse oocytes reveals 28 candidate factors of the “reprogrammome”. J Proteome Res, 10:2140–2153.
226.
PfenderS, KuznetsovV, PasternakM, TischerT, SanthanamB and SchuhM. (2015). Live imaging RNAi screen reveals genes essential for meiosis in mammalian oocytes. Nature, 524:239–242.
227.
TatoneC, Di EmidioG, VittiM, Di CarloM, SantiniSJr., D'AlessandroAM, FaloneS and AmicarelliF. (2015). Sirtuin functions in female fertility: possible role in oxidative stress and aging. Oxid Med Cell Longev, 2015:659687.
228.
Martinez-DiazMA, CheL, AlbornozM, SenedaMM, CollisD, CoutinhoAR, El-BeirouthiN, LaurinD, ZhaoX and BordignonV. (2010). Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. Cell Reprogram, 12:85–94.
229.
KidderBL, HuG and ZhaoK. (2014). KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation. Genome Biol, 15:R32.
230.
OogaM, InoueA, KageyamaS, AkiyamaT, NagataM and AokiF. (2008). Changes in H3K79 methylation during preimplantation development in mice. Biol Reprod, 78:413–424.
231.
OogaM, SuzukiMG and AokiF. (2013). Involvement of DOT1L in the remodeling of heterochromatin configuration during early preimplantation development in mice. Biol Reprod, 89:145.
232.
DiaoYF, OqaniRK, LiXX, LinT, KangJW and JinDI. (2014). Changes in histone H3 lysine 36 methylation in porcine oocytes and preimplantation embryos. PLoS One, 9:e100205.
233.
Di BernardiniE, CampagnoloP, MargaritiA, ZampetakiA, KaramaritiE, HuY and XuQ. (2014). Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways. J Biol Chem, 289:3383–3393.
234.
MercerTR, QureshiIA, GokhanS, DingerME, LiG, MattickJS and MehlerMF. (2010). Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci, 11:14.
235.
RapicavoliNA, PothEM and BlackshawS. (2010). The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Dev Biol, 10:49.
236.
BarryG, BriggsDP, VanichkinaEM, PothNJ, BeveridgeVS, RatnuSP, NaylerK, NonesJ, HuTWB, et al. (2014). The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol Psychiatry, 19:486–494.
237.
BertaniS, SauerS, BolotinE and SauerF. (2011). The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell, 43:1040–1046.
238.
LinN, ChangKY, LiZ, GatesK, RanaZA, DangJ, ZhangD, HanT, YangCS, et al. (2014). An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment. Mol Cell, 53:1005–1019.
239.
LoewerS, CabiliMN, GuttmanM, LohYH, ThomasK, ParkIH, GarberM, CurranM, OnderT, et al. (2010). Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet, 42:1113–1117.
240.
WangY, XuZ, JiangJ, XuC, KangJ, XiaoL, WuM, XiongJ, GuoX and LiuH. (2013). Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell, 25:69–80.
241.
ZhangA, ZhouN, HuangJ, LiuQ, FukudaK, MaD, LuZ, BaiC, WatabeK and MoYY. (2013). The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res, 23:340–350.
242.
BaoX, WuH, ZhuX, GuoX, HutchinsAP, LuoZ, SongH, ChenY, LaiK, et al. (2015). The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res, 25:80–92.
